Cytovale is a medical diagnostics company developing innovative technologies for the rapid detection and assessment of immune-mediated diseases. By combining advanced biophysical analysis with routine blood samples, the company enables clinicians to identify high-risk patients earlier, supporting faster clinical decisions and improved patient outcomes in time-critical care settings.